Pacer Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,999
| Closed | -$447K | – | 3562 |
|
|
2025
Q1 | $447K | Sell |
6,999
-13,056
| -65% | -$833K | ﹤0.01% | 1484 |
|
|
2024
Q4 | $2.44M | Sell |
20,055
-932
| -4% | -$113K | 0.01% | 880 |
|
|
2024
Q3 | $2.62M | Buy |
20,987
+5,989
| +40% | +$748K | 0.01% | 837 |
|
|
2024
Q2 | $2.37M | Buy |
14,998
+14,654
| +4,260% | +$2.32M | 0.01% | 831 |
|
|
2024
Q1 | $44.5K | Buy |
+344
| New | +$44.5K | ﹤0.01% | 3214 |
|
|
2021
Q2 | – | Sell |
-895
| Closed | -$67K | – | 1545 |
|
|
2021
Q1 | $67K | Buy |
895
+66
| +8% | +$4.94K | ﹤0.01% | 1393 |
|
|
2020
Q4 | $141K | Buy |
829
+168
| +25% | +$28.6K | ﹤0.01% | 1292 |
|
|
2020
Q3 | $93K | Buy |
+661
| New | +$93K | ﹤0.01% | 1259 |
|
|
2018
Q4 | – | Sell |
-2,580
| Closed | -$417K | – | 974 |
|
|
2018
Q3 | $417K | Buy |
+2,580
| New | +$417K | 0.02% | 900 |
|
|
2018
Q1 | – | Sell |
-2,600
| Closed | -$145K | – | 1123 |
|
|
2017
Q4 | $145K | Buy |
+2,600
| New | +$145K | 0.01% | 927 |
|